Aquatic Capital Management Boosts Stake in Exact Sciences

The investment firm increased its position in the medical research company by 213.6% during the third quarter.

Mar. 16, 2026 at 7:23am

Got story updates? Submit your updates here. ›

Aquatic Capital Management LLC increased its stake in Exact Sciences Corporation (NASDAQ:EXAS) by 213.6% during the third quarter, according to a recent SEC filing. The fund now owns 194,273 shares of the medical research company's stock, worth $10.6 million at the end of the reporting period.

Why it matters

Exact Sciences is a leading molecular diagnostics company known for its Cologuard colorectal cancer screening test. The increase in Aquatic Capital's position suggests the firm sees growth potential in the company's business and products.

The details

According to the 13F filing, Aquatic Capital Management added 132,331 shares of Exact Sciences to its portfolio during the third quarter. This brought the firm's total holdings in the company to 194,273 shares, representing a 213.6% increase from the previous quarter.

  • Aquatic Capital Management increased its Exact Sciences position during the third quarter of 2026.

The players

Aquatic Capital Management LLC

An investment management firm that increased its stake in Exact Sciences Corporation.

Exact Sciences Corporation

A medical research company known for its Cologuard colorectal cancer screening test.

Got photos? Submit your photos here. ›

The takeaway

Aquatic Capital Management's significant increase in its Exact Sciences position suggests the firm sees strong growth potential in the company's medical diagnostics business, particularly its flagship Cologuard test.